2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with Benign Neoplasms in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 4 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fedorov, AY; Gavryushin, AE; Kudriashova, ES; Kuzmina, NS; Nyuchev, AV; Otvagin, VF | 1 |
Cai, W; Duan, Y; Lv, W; Meng, L; Zhang, L | 1 |
Borah, B; Cacaccio, J; Cheruku, RR; Durrani, F; Ethirajan, M; Missert, JR; Pandey, RK; Pera, P; Tabaczynski, W | 1 |
Bricks, JL; Chepurna, OM; Levchenko, SM; Losytskyy, MY; Nikolaeva, OA; Ohulchanskyy, TY; Qu, J; Slominskii, YL; Vretik, LO; Xu, H; Yakovliev, A; Ziniuk, R | 1 |
Chen, Y; Goswami, LN; James, NS; Joshi, P; Ohulchanskyy, TY; Pandey, RK; Zheng, X | 1 |
Bhirde, A; Chen, X; Kiesewetter, DO; Liu, Z; Nie, L; Niu, G; Rong, P; Srivastan, A; Wang, F; Wang, W; Wang, Z; Yang, K; Yue, X | 1 |
Carter, KA; Geng, J; Lin, C; Lovell, JF; Luo, D; Ortega, J; Razi, A; Shao, S | 1 |
Kim, MM; Liu, B; Penjweini, R; Zhu, TC | 1 |
Batt, C; Chen, Y; Ethirajan, M; Goswami, L; Mazurchuk, R; Missert, JR; Pandey, RK; Patel, NJ; Spernyak, JA; Turowski, S; White, WH | 1 |
Chen, Y; Ethirajan, M; Joshi, P; Pandey, RK | 1 |
Bellnier, DA; Dougherty, TJ; Greco, WR; Loewen, GM; Nava, H; Oseroff, AR; Pandey, RK; Tsuchida, T | 1 |
Bellnier, DA; Dougherty, TJ; Greco, WR; Loewen, GM; Nava, H; Oseroff, AR | 1 |
2 review(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Benign Neoplasms
Article | Year |
---|---|
Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Light; Metalloporphyrins; Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2022 |
The role of porphyrin chemistry in tumor imaging and photodynamic therapy.
Topics: Animals; Chlorophyll; Esophageal Neoplasms; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2011 |
10 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Benign Neoplasms
Article | Year |
---|---|
The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer.
Topics: Animals; Cell Line, Tumor; Lasers; Mice; Mice, Nude; Neoplasms; Receptor, ErbB-2; Ultrasonography | 2023 |
Pluronic F-127: An Efficient Delivery Vehicle for 3-(1'-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH or Photochlor).
Topics: Animals; Cell Line, Tumor; Chlorophyll; Humans; Mice; Mice, Inbred BALB C; Neoplasms; Photochemotherapy; Photosensitizing Agents; Poloxamer; Xenograft Model Antitumor Assays | 2020 |
Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Topics: Acrylic Resins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chlorophyll; Drug Compounding; Fluorescent Dyes; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Nanocapsules; Neoplasms; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Polymers; Polystyrenes; Singlet Oxygen; Tissue Distribution | 2020 |
Comparative tumor imaging and PDT Efficacy of HPPH conjugated in the mono- and di-forms to various polymethine cyanine dyes: part - 2.
Topics: Animals; Chlorophyll; Disease Models, Animal; Fluorescent Dyes; Humans; Indoles; Mice, Nude; Neoplasms; Optical Imaging; Pathology, Clinical; Photochemotherapy; Staining and Labeling | 2013 |
Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chlorophyll; Copper Radioisotopes; Graphite; Mice; Microscopy, Fluorescence; Multimodal Imaging; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Positron-Emission Tomography | 2014 |
Porphyrin-phospholipid liposomes with tunable leakiness.
Topics: Animals; Antibiotics, Antineoplastic; Biological Availability; Chlorophyll; Doxorubicin; Drug Compounding; Drug Stability; Female; HeLa Cells; Humans; Injections, Intravenous; Liposomes; Mice, Nude; Neoplasms; Phospholipids; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Solubility; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Topics: Animals; Chlorophyll; Disease Models, Animal; Female; Fibrosarcoma; Light; Mice; Mice, Inbred C3H; Necrosis; Neoplasms; Photochemotherapy; Photosensitizing Agents; Radiometry; Singlet Oxygen | 2015 |
Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy.
Topics: Animals; Chlorophyll; Fluorescence; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms; Photochemotherapy; Rats | 2010 |
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Blood Proteins; Carcinoma, Basal Cell; Chlorophyll; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Esophageal Neoplasms; Humans; Lung Neoplasms; Middle Aged; Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms | 2003 |
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
Topics: Administration, Topical; Aminolevulinic Acid; Chlorophyll; Dihematoporphyrin Ether; Fluorometry; Half-Life; Humans; Infusions, Intravenous; Neoplasms; Photosensitizing Agents | 2006 |